SL-V20

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameSL-V20

Drug Alias NameSL-V20

ClassificationVaccines > Application > Prophylactic vaccineVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Biological material > Viral vaccine

Mechanisms of ActionImmunostimulants

TargetsNot applicable

Therapy Area/IndicationsHerpes Genitalis

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesSl Vaxigen

China Registration ClassN/A

Develop Information

Active CompaniesSl Vaxigen

Inactive CompaniesN/A

Active IndicationsHerpes Genitalis

Inactive IndicationsN/A

Other Information

ATC CodeN/A